Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. [electronic resource]
- Journal of immunology (Baltimore, Md. : 1950) Mar 2001
- 3873-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0022-1767
10.4049/jimmunol.166.6.3873 doi
Animals Anti-Inflammatory Agents, Non-Steroidal--antagonists & inhibitors Arginine--pharmacology Cell Line Cell Survival--drug effects Culture Media Cyclooxygenase 2 Drug Combinations Drug Synergism Hydrazines--pharmacology Inflammation Mediators--antagonists & inhibitors Interleukin-6--antagonists & inhibitors Isoenzymes--antagonists & inhibitors Lipopolysaccharides--immunology Macrophage Activation--drug effects Macrophages--drug effects Mice NF-kappa B--antagonists & inhibitors NG-Nitroarginine Methyl Ester--pharmacology Nitric Oxide--antagonists & inhibitors Nitric Oxide Synthase--antagonists & inhibitors Nitric Oxide Synthase Type II Nitrogen Oxides Prostaglandin-Endoperoxide Synthases--biosynthesis RNA, Messenger--antagonists & inhibitors Time Factors